Optimising the management of multiple myeloma in the early relapsed/refractory setting

Thursday, May 30th 2024
17:30
19:00
BST
18:30
20:00
CEST

About This Meeting

A virtual Experts Knowledge Share on the topic of ‘Optimising the management of multiple myeloma in the early relapsed/refractory setting’ with Scientific Committee Assoc. Prof. Karthik Ramasamy (UK), Prof. Aurore Perrot (France), Prof. Hermann Einsele (Germany) and Assoc. Prof. Joshua Richter (USA)

Topics of conversation include:

  1. Challenges of optimising treatment for early relapsed/refractory multiple myeloma (RRMM) in the era of multiple novel therapies
  2. Current treatments for early RRMM: Linking mechanism of action to efficacy
  3. Best practices in combining and sequencing therapies for optimal outcomes in RRMM
  4. Insights from clinical practice on how to manage tolerability and safety
  5. Patient case study discussions

This event is in collaboration with LYMPHOMA & MYELOMA CONNECT, an international group of experts in the field of hematological malignancies.

You will also have the opportunity to contribute to the discussion on this important topic. An honorarium of 100 EUROS is offered to HCPs for active participation and for completing the pre-meeting survey.

In registering for this meeting you are joining the COR2ED community. We will keep you informed of future meetings and programmes of interest.

Please submit your patient case study/questions for the faculty to selina.gill@cor2ed.com

Meeting Materials

To view meeting materials, you need to be registered for the meeting.

Faculty

Assoc. Prof. Karthik Ramasamy
Hematologist Oncologist
​​​Oxford University Hospitals NHS Trust, UK
Prof. Aurore Perrot
Hematologist
University of Toulouse, France
Prof. Hermann Einsele
Hematologist Oncologist
University of Würzburg, Germany
Assoc. Prof. Joshua Richter
Hematologist Oncologist
Icahn School of Medicine at Mount Sinai, USA

Faculty

Assoc. Prof. Karthik Ramasamy

Hematologist Oncologist
​​​Oxford University Hospitals NHS Trust, UK

Prof. Aurore Perrot

Hematologist
University of Toulouse, France

Prof. Hermann Einsele

Hematologist Oncologist
University of Würzburg, Germany

Assoc. Prof. Joshua Richter

Hematologist Oncologist
Icahn School of Medicine at Mount Sinai, USA
LYMPHOMA & MYELOMA CONNECT Is an initiative of COR2ED. This programme is supported by an Independent Medical Education Grant from Menarini Stemline Oncology

COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved 
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept